News

EnteroBiotix Strengthens its Executive Team, Appoints COO and CFO

GLASGOW, Scotland, Feb. 01, 2024 (GLOBE NEWSWIRE) -- EnteroBiotix Limited (“EBX”), a clinical stage biopharmaceutical company with the premier platform…

2 years ago

Launch of GIO Therapeutics, founded by Cumulus Oncology, to develop therapeutics targeting G protein-coupled receptors to treat cancer and inflammation

Launch of GIO Therapeutics, founded by Cumulus Oncology, to develop therapeutics targeting G protein-coupled receptors to treat cancer and inflammation…

2 years ago

Legacy Novozymes delivers solid last full-year results

Legacy Novozymes is delivering solid growth and earnings in a year characterized by changing market demands, with 6% organic sales…

2 years ago

Genflow Biosciences Releases 2023 Year-End Review and Highlights Key Priorities for 2024

Genflow Biosciences Plc ("Genflow" or "the Company") LONDON, Feb. 01, 2024 (GLOBE NEWSWIRE) -- The Company (LSE:GENF) (OTCQB:GENFF), an emerging…

2 years ago

Kuros Biosciences to Present at the CG 2024 Musculoskeletal Conference

ZURICH, SWITZERLAND / ACCESSWIRE / February 1, 2024 / Kuros Biosciences ("Kuros" or "the Company"), a leader in next generation…

2 years ago

Boomerang Medical Awarded “Promising Up-and-Comer in the Fight Against Ulcerative Colitis and Crohn’s Disease” by the Crohn’s & Colitis Foundation

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Boomerang Medical, a women-led bioelectronic medicine company, received the Corporate Circle Award for "Promising Up-and-Comer in the…

2 years ago

Moderna Named to Fortune’s List of World’s Most Admired Companies

CAMBRIDGE, MA / ACCESSWIRE / January 31, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced it has been recognized on Fortune's…

2 years ago

Takeda and Protagonist Therapeutics, Inc. Enter into Worldwide License and Collaboration Agreement for Rusfertide, a Late-Stage Rare Hematology Asset

Takeda Will Be Protagonist's Co-Development, U.S. Co-Commercialization Partner With 50:50 Profit Share, and With Exclusive Ex-U.S. Global Rights to Commercialize…

2 years ago

GE HealthCare Announces Prucka 3 Digital Amplifier as Next Generation Platform for Electrophysiology Innovation

Latest digital platform provides key advancements to help maintain high signal fidelity while reducing environmental noise Forward-looking platform designed to…

2 years ago

United States Ambulatory Surgery Center Market Report 2023: Comprehensive Insights Reveal Surge in Hybrid ASC/OBL Models and Technological Innovations – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "2023 United States Ambulatory Surgery Center Market Report" report has been added to ResearchAndMarkets.com's offering. The in-depth analysis…

2 years ago